Showing results (1-10 of 968) with videos related to
Sort By:
Pageof 97
Expert Opinion on Emerging Drugs|February 10, 2024
Targeting the PACAP-38 pathway is an emerging therapeutic strategy for migraine preventionLanfranco Pellesi, Messoud Ashina, Paolo MartellettiThe Journal of Headache and Pain|September 28, 2018
Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache FederationLars Bendtsen, Simona Sacco, Messoud Ashina, et al.The Journal of Headache and Pain|January 18, 2019
European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine preventionSimona Sacco, Lars Bendtsen, Messoud Ashina, et al.The Journal of Headache and Pain|May 25, 2019
Correction to: European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine preventionSimona Sacco, Lars Bendtsen, Messoud Ashina, et al.CNS & Neurological Disorders Drug Targets|August 19, 2007
Pathophysiology of tension-type headache: potential drug targetsMessoud AshinaExpert Opinion on Pharmacotherapy|April 6, 2002
Nitric oxide synthase inhibitors for the treatment of chronic tension-type headacheMessoud AshinaCurrent Pain and Headache Reports|November 8, 2003
Current and potential future drug therapies for tension-type headacheSait Ashina, Messoud AshinaCephalalgia : an International Journal of Headache|January 10, 2015
Can nitric oxide induce migraine in normal individuals?Jes Olesen, Messoud AshinaTrends in Pharmacological Sciences|April 5, 2011
Emerging migraine treatments and drug targetsJes Olesen, Messoud AshinaCephalalgia : an International Journal of Headache|January 24, 2014
Calcitonin gene-related peptide and migraine with aura: A systematic reviewJakob M Hansen, Messoud AshinaPageof 97